Polymorphisms of innate immunity genes influence disease progression in HIV-1-infected children

AIDS

Volumn 26, Issue 6, 2012, Pages 765-768

  Freguja, Riccardo ^a   Gianesin, Ketty ^a   Del Bianco, Paola ^a   Malacrida, Sandro ^a   Rampon, Osvalda ^a   Zanchetta, Marisa ^a   Giaquinto, Carlo ^a   De Rossi, Anita ^a  

^a UNIVERSITY OF PADOVA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

DEFENSIN; TOLL LIKE RECEPTOR;

ARTICLE; DEFBETA1 GENE; DISEASE COURSE; GENETIC POLYMORPHISM; GENOTYPE; HAPLOTYPE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; INNATE IMMUNITY; MAJOR CLINICAL STUDY; NONHUMAN; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RECEPTOR GENE; SINGLE NUCLEOTIDE POLYMORPHISM; TLR9 GENE;

BETA-DEFENSINS; CHILD; CHILD, PRESCHOOL; DISEASE PROGRESSION; GENETIC PREDISPOSITION TO DISEASE; HIV INFECTIONS; HIV-1; HUMANS; IMMUNITY, INNATE; INFANT; INFANT, NEWBORN; POLYMORPHISM, SINGLE NUCLEOTIDE; TOLL-LIKE RECEPTOR 9;

EID: 84859027272     PISSN: 02699370     EISSN: 14735571     Source Type: Journal    
DOI: 10.1097/QAD.0b013e3283514350     Document Type: Article

References (21)

1. De Rossi A, Masiero S, Giaquinto C, Ruga E, Comar M, Giacca M, Chieco-Bianchi L. Dynamics ofviral replication in infants with vertically acquired human immunodeficiency virus type 1 infection. J Clin Invest 1996; 97:323-330. (Pubitemid 26039394)
2. Bochud PY, Hersberger M, Taffé P, Bochud M, Stein CM, Rodrigues SD, et al. Polymorphisms inToll-like receptor 9 influence the clinical course of HIV-1 infection. AIDS 2007; 21:441-446.
3. Soriano-Sarabia N, Vallejo A, Ramirez-Lorca R, del Mar Rodriguez M, Salinas A, Pulido I, et al. Influence ofthe Toll-like receptor 9 1635 A/G polymorphism on the CD4 count, HIV viral load and clinical progression. J Acquir Immune Defic Syndr 2008; 49:128-135.
4. Pine SO, McElrath MJ, Bochud PY. Polymorphisms intoll-like receptor 4 and toll-like receptor 9 influence viral load in a seroincident cohort of HIV-1-infected individuals. AIDS 2009; 23:2387-2395.
5. Ricci E, Malacrida S, Zanchetta M, Mosconi I, Montagna M, Giaquinto C, De Rossi A. Toll-like receptor 9polymorphisms influence mother-to-child transmission of human immunodeficiency virus type 1. J Transl Med 2010; 8:49.
6. Braida L, Boniotto M, Pontillo A, Tovo PA, Amoroso A, Crovella S. A single-nucleotide polymorphism inthe human beta-defensin 1 gene is associated with HIV-1 infection in Italian children. AIDS 2004; 18:1598-1600. (Pubitemid 39037486)
7. Milanese M, Segat L, Pontillo A, Arraes LC, de Lima Filho JL, Crovella S. DEFB1 gene polymorphisms and increased risk of HIV-1 infection in Brazilian children. AIDS 2006; 20:1673-1675. (Pubitemid 44162413)
8. Ricci E, Malacrida S, Zanchetta M, Montagna M, Giaquinto C, De Rossi A. Role ofb-defensin-1 polymorphisms in mother-child transmission of HIV-1. J Acquir immune Defic Syndr 2009; 51:13-19.
9. Centers for Disease Control and Prevention. Revised classification system for human immunodeficiency virus infection in children less than 13 years of age. MM WR Morb Mortal Wkly Rep 1994; 43:1-10.
10. Tregouet DA, Tiret L, Eur J. Cox proportional hazards survival regression in haplotype-based association analysis using the Stochastic-EM algorithm. Hum Genet 2004; 12:971-974. (Pubitemid 39462132)
11. Altrock PM, Traulsen A, Reeves RG, Reed FA. Using under-dominance tobi-stably transform local populations. J Theor Biol 2010; 267:62-75.
12. Menendez A, Brett Finlay B. Defensins inthe immunology of bacterial infections. Curr Opin Immunol 2007; 19:385-391. (Pubitemid 47284860)
13. Zapata W, Rodriguez B, Weber J, Estrada H, Quiñones-Mateu ME, Zimermman PA, et al. Increased levels ofhuman beta-defensins mRNA in sexually HIV-1 exposed but uninfected individuals. Curr HIV Res 2008; 6:531-538.
14. Sun CQ, Arnold R, Fernandez-Golarz C, Parrish AB, Almekinder T, He J, et al. Human beta-defensin-1, apotential chromosome 8p tumor suppressor: control of transcription and induction of apoptosis in renal cell carcinoma. Cancer Res 2006; 66:8542-8549. (Pubitemid 44449167)
15. Brenchley JM, Price DA, Schacker TW, Asher TE, Silvestri G, Rao S, et al. Microbial translocation is acause of systemic immune activation in chronic HIV infection. Nat Med 2006; 12:1365-1371. (Pubitemid 44924494)
16. Anselmi A, Vendrame D, Rampon O, Giaquinto C, Zanchetta M, De Rossi A. Immune reconstitution inhuman immunodeficiency virus type 1-infected children with different virological responses to antiretroviral therapy. Clin Exp Immunol 2007; 150:442-450. (Pubitemid 350098747)
17. Freguja R, Gianesin K, Mosconi I, Zanchetta M, Carmona F, Rampon O, et al. Regulatory Tcells and chronic immune activation in human immunodeficiency virus 1 (HIV-1)-infected children. Clin Exp Immunol 2011; 164:373-380.
18. Akira S, Uematsu S, Takeuchi O. Pathogen recognition and innate immunity. Cell 2006; 124:783-801. (Pubitemid 43261452)
19. Uematsu S, Akira S. Toll-like receptors and innate immunity. J Mol Med 2006; 84:712-725. (Pubitemid 44328063)
20. Jiang W, Lederman MM, Mohner RJ, Rodriguez B, Nedrich TM, Harding CV, Sieg SF. Impaired naive and memory B-cell responsiveness to TLR9 stimulation in human immunodeficiency virus infection. J Virol 2008; 82:7837-7845.
21. Tao K, Fujii M, Tsukumo S, Maekawa Y, Kishihara K, Kimoto Y, et al. Genetic variations ofToll-like receptor 9 predispose to systemic lupus erythematosus in Japanese population. Ann Rheum Dis 2007; 66:905-909. (Pubitemid 46999791)